Kisner Daniel L is a director of Zynerba Pharmaceuticals, Inc.
Person profile
Roles
Zynerba Pharmaceuticals
Director
Oncternal Therapeutics
Director
Histogen
Director
Dynavax Technologies
Director
Address
Carlsbad, California
Employees
Incorporated
Fiscal year end
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Zynerba Pharmaceuticals, Inc.
11 Oct 23
4
Oncternal Therapeutics, Inc.
30 Jun 23
4
Histogen Inc.
21 Jun 23
4
Zynerba Pharmaceuticals, Inc.
15 Jun 23
4
DYNAVAX TECHNOLOGIES CORP
31 May 23
4
Oncternal Therapeutics, Inc.
17 Jun 22
4
Zynerba Pharmaceuticals, Inc.
16 Jun 22
4
Histogen Inc.
3 Jun 22
4
DYNAVAX TECHNOLOGIES CORP
27 May 22
4
Histogen Inc.
3 Sep 21
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
10 Oct 23 | ZYNE Zynerba Pharmaceuticals | Common Stock | Dispose U | No | No | 0 | 47,824 | 0.00 | 0 | |
10 Oct 23 | ZYNE Zynerba Pharmaceuticals | Common Stock | Dispose U | No | No | 0 | 27,954 | 0.00 | 47,824 | |
10 Oct 23 | ZYNE Zynerba Pharmaceuticals | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 0.3501 | 71,736 | 25.11 k | 0 |
10 Oct 23 | ZYNE Zynerba Pharmaceuticals | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 1.01 | 34,663 | 35.01 k | 0 |
28 Jun 23 | ONCT Oncternal Therapeutics | Stock Options Common Stock | Grant | Acquire A | No | No | 0.3553 | 25,000 | 8.88 k | 25,000 |
20 Jun 23 | HSTO Histogen | Stock Option Common Stock | Grant | Acquire A | No | No | 0.828 | 6,835 | 5.66 k | 6,835 |
14 Jun 23 | ZYNE Zynerba Pharmaceuticals | Common Stock | Sell | Dispose S | No | No | 0.3481 | 115 | 40.03 | 75,778 |
13 Jun 23 | ZYNE Zynerba Pharmaceuticals | Common Stock | Grant | Acquire A | No | No | 0 | 47,824 | 0.00 | 75,893 |
13 Jun 23 | ZYNE Zynerba Pharmaceuticals | Stock Option Common Stock | Grant | Acquire A | No | No | 0.3501 | 71,736 | 25.11 k | 71,736 |
26 May 23 | DVAX Dynavax Technologies | Common Stock | Grant | Acquire A | No | No | 0 | 5,357 | 0.00 | 12,214 |